The Food and Drug Administration (FDA) of the United States has revealed its plan to phase out animal testing requirements for new drug products and related items, opting for testing on artificial intelligence models closely resembling humans instead. This shift in testing methods is set to be implemented starting next year, with only select companies being allowed to follow the non-animal testing approach. This approach offers advantages in terms of safety, cost reduction in research and development, quicker product release, and addresses ethical concerns surrounding animal testing.
The AI models utilized will predict the body’s response to drugs and their potential side effects through the use of human body simulation software. Additionally, there are plans to develop organ models created in laboratory settings or chip technologies that mimic bodily functions to assess the side effects that may occur.
Source: Axios | Image by Pixabay
TLDR: The FDA plans to replace animal testing with AI models for drug testing, providing safer, cost-effective, and quicker results while addressing ethical concerns.
Leave a Comment